Becker's Healthcare August 29, 2024
Jakob Emerson

A federal lawmaker investigating pharmacy benefit managers is accusing top executives from CVS Health, Cigna Group and UnitedHealth Group of making false statements during a committee hearing in July.

On Aug. 28, Rep. James Comer, chair of the House Committee on Oversight and Accountability, called on three PBM executives “to correct the record” regarding testimonies they made during a hearing about how the PBM industry influences prescription drug markets.

“At our hearing, the witnesses claimed they do not steer patients to PBM-owned pharmacies,” the committee wrote on X. “The executives also made claims contradicting the committee’s and FTC’s findings regarding contract negotiations, contract opt outs, and payments to pharmacies.”

Mr. Comer is asking David Joyner, president of CVS Caremark; Adam...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Congress / White House, Govt Agencies, Pharma, Pharma / Biotech
Roche Welcomes FDA Approvals for Injectable Versions of MS and Cancer Drugs
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
Does PBM Market Share Vary by Payer Type?
Allowing Medicare to Negotiate Drug Prices Remains Broadly Popular Among Voters, Though Most Are Unaware of the Law and Its Projected Savings
Pharma Pulse 9/13/24: AI Adoption for Clinical Trial Design, Comparing Biologics and Biosimilars & more

Share This Article